What’s Ahead for MEDOVEX CORP (OTCMKTS:MDVX) After Less Shorted Shares?

May 10, 2018 - By marketbeat

MedoveX Corp. (OTCMKTS:MDVX) Logo

The stock of MEDOVEX CORP (OTCMKTS:MDVX) registered a decrease of 56.39% in short interest. MDVX’s total short interest was 9,900 shares in May as published by FINRA. Its down 56.39% from 22,700 shares, reported previously. With 16,400 shares average volume, it will take short sellers 1 days to cover their MDVX’s short positions. The short interest to MEDOVEX CORP’s float is 0.08%.

It closed at $0.4 lastly. It is down 69.11% since May 10, 2017 and is downtrending. It has underperformed by 80.66% the S&P500.

MedoveX Corporation, through its subsidiaries, focuses on developing medical devices primarily in the United States and Europe. The company has market cap of $8.77 million. It offers DenerveX device, a disposable single-use kit for the treatment of various medical applications, including pain relief. It currently has negative earnings. The firm serves healthcare providers, physicians, and third-party payors.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter: